Clinical outcomes of 54 pelvic osteosarcomas registered by Japanese Musculoskeletal Oncology Group

Oncology

Volumn 68, Issue 4-6, 2005, Pages 375-381

  Matsuo, Toshihiro ^a   Sugita, Takashi ^b   Sato, Keiji ^c   Hotta, Tetsuo ^d   Tsuchiya, Hiroyuki ^e   Shimose, Shoji ^a   Kubo, Tadahiko ^a   Ochi, Mitsuo ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

Author keywords

Clinical outcomes; Osteosarcoma; Pelvis; Prognostic factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIENCE; FEMALE; HEALTH CARE ORGANIZATION; HEMIPELVECTOMY; HUMAN; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OSTEOSARCOMA; OUTCOMES RESEARCH; PATIENT MOBILITY; PELVIS CANCER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; OSTEOSARCOMA; PELVIC BONES; PELVIC NEOPLASMS; PROGNOSIS; REGISTRIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 23844504576     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086978     Document Type: Article

References (25)

1. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG: Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery. Cancer 1979;43:2163-2177.
2. Enneking WF, Dunham WK: Resection and reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg 1978;60A:731-746.
3. Gherlinzoni F, Picci P, Bacci G, Campanacci D: Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience. Ann Oncol 1992;3(suppl 2):23-27.
4. Wurtz LD, Peabody TD, Simon MA: Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis. J Bone Joint Surg 1999;81A:317-325.
5. Bielack SS, Wulff B, Delling G, Gobel U, Kotz R, Ritter J, Winkler K: Osteosarcoma of the trunk treated by multimodal therapy: Experience of the Cooperative Osteosarcoma study group (COSS). Med Pediatr Oncol 1995;24:6-12.
6. Enneking WF: A system of staging musculoskeletal neoplasms. Clin Orthop 1986;204:9-24.
7. Kawaguchi N, Matumoto S, Manabe J: New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma, analysed on the basis of 457 surgical cases. J Cancer Res Clin Oncol 1995;121:555-563.
8. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C: Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982;49:1221-1230.
9. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ: A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 1993;286:241-246.
10. Ham SJ, Schraffordt Koops H, van der Graaf WT, van Horn JR, Postma L, Hoekstra HJ: Historical, current and future aspects of osteosarcoma treatment. Eur J Surg Oncol 1998;24:584-600.
11. Fahey M, Spanier SS, Vander Griend RA: Osteosarcoma of the pelvis. A clinical and histopathological study of twenty-five patients. J Bone Joint Surg 1992;74A:321-330.
12. Shin KH, Rougraff BT, Simon MA: Oncologic outcomes of primary bone sarcomas of the pelvis. Clin Orthop 1994;304:207-217.
13. Kawai A, Huvos AG, Meyers PA, Healey JH: Osteosarcoma of the pelvis. Oncologic results of 40 patients. Clin Orthop 1998;348:196-207.
14. Ham SJ, Kroon HM, Koops HS, Hoekstra HJ: Osteosarcoma of the pelvis - Oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol 2000;26:53-60.
15. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jurgens H, Winkler K: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776-790.
16. Ozaki T, Flege S, Kevric M, Lindner N, Maas R, Delling G, Schwarz R, von Hochstetter AR, Salzer-Kuntschik M, Berdel WE, Jurgens H, Exner GU, Reichardt P, Mayer-Steinacker R, Ewerbeck V, Kotz R, Winkelmann W, Bielack SS: Osteosarcoma of the pelvis: Experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol 2003;21:334-341.
17. Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, Bielack S, Heise U, Jurgens H, Treuner J, Romanowski R, Exner U, Kotz R, Winkler K: Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 1996;14:848-858.
18. Apffelstaedt JP, Driscoll DL, Spellman JE, Velez AF, Gibbs JF, Karakousis CP: Complications and outcome of external hemipelvectomy in the management of pelvic tumors. Ann Surg Oncol 1996;3:304-309.
19. Yokoyama R, Beppu Y, Tobisu Ki K, Moriya Y, Uchiyama K, Kito M, Umeda T, Hasegawa T, Shimoda T: A multidisciplinary approach to the treatment of malignant pelvic bone tumors: Results with eight consecutive patients. J Orthop Sci 2000;5:449-456.
20. Gunterberg B, Kewenter J, Petersen I, Stener B: Anorectal function after major resections of the sacrum with bilateral or unilateral sacrifice of sacral nerves. Br J Surg 1976;63:546-554.
21. O'Connor MI, Sim FH: Salvage of the limb in the treatment of malignant pelvic tumors. J Bone Joint Surg 1989;71A:481-494.
22. Raque GH Jr, Vitaz TW, Shields CB: Treatment of neoplastic diseases of the sacrum. J Surg Oncol 2001;76:301-307.
23. Ozaki T, Hillmann A, Bettin D, Wuisman P, Winkelmann W: High complication rates with pelvic allografts. Experience of 22 sarcoma resections. Acta Orthop Scand 1996;67:333-338.
24. Bruland OS, Skretting A, Solheim OP, Aas M: Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach. Acta Oncol 1996;35:381-384.
25. Anderson PM, Wiseman GA, Dispenzieri A, Arndt CA, Hartmann LC, Smithson WA, Mullan BP, Bruland OS: High-dose samarium-153 ethylene diamine tetramethylene phosphonate: Low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol 2002;20:189-196.